Hyderabad, March 18 -- Mankind Pharma Limited on Wednesday announced the acquisition of the Rivotril brand from Roche for the Indian market, securing exclusive rights to manufacture, market and distribute the product across the country.
Rivotril, the innovator brand of clonazepam, is widely prescribed for neurological and psychiatric conditions and is regarded as a "textbook" brand with strong clinical legacy and recall among specialists.
The acquisition is aimed at strengthening Mankind Pharma's presence in the central nervous system (CNS) therapy segment and aligns with its broader strategy to expand in chronic and specialty therapies, the Pharmaceutical company said in a release..
The company said chronic therapies are contributing an...